Inventor · disambiguated record
Sudhakar Devidasrao Garad
Also filed as: GARAD SUDHAKAR · GARAD SUDHAKAR D · GARAD SUDHAKAR DEVIDASRAO
6 granted patents·2 pending applications·16 citations·filing 2005–2015
75Inventor score
Files withCUBIST PHARM INC2STOWASSER FRANK2GARAD SUDHAKAR DEVIDASRAO1MERCK SHARP & DOHME1NOVARTIS AG1
Top patents by PatentIndex Score
8 records- 0184US9120795B2Crystalline form of a β-lactamase inhibitorCUBIST PHARM INC·Filed 2014·Granted Sep 1, 2015·5 cites·20 claims
- 0281US8436177B2Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrileSTOWASSER FRANK·Filed 2007·Granted May 7, 2013·8 cites·32 claims
- 0378US7723356B2Quinuclidine derivatives and their use as muscarinic m3 receptor antagonistsNOVARTIS AG·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 0455US10000510B2Salt forms of ceftolozaneMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·9 claims
- 0546US2015111864A1Crystalline form of a beta-lactamase inhibitorCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 0645US2013289064A1Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrileSTOWASSER FRANK·Filed 2013·Application pending·0 cites
- 0740US8084463B2Quinuclidine derivatives and their use as muscarinic M3 receptor antagonistsPRESS NEIL J·Filed 2010·Granted Dec 27, 2011·0 cites·7 claims
- 0830US9011833B2Vitamin E formulations of sulfamide NS3 inhibitorsGARAD SUDHAKAR DEVIDASRAO·Filed 2011·Granted Apr 21, 2015·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →